About
Acceptance Rate
67%Time to first decision
40 days*Time from acceptance to publication
22 days*2020 total content views
11,768Aims and scope
BMJ Surgery, Interventions, & Health Technologies is an open access journal that publishes original research on complex healthcare interventions. Intended to encourage higher standards of science and more rapid dissemination of new knowledge in the field, it provides a high-impact international platform for both early and later stage clinical studies as well as long-term assessment and surveillance studies that meet high standards of design and reporting. It actively promotes the adoption of an IDEAL-based model of an evaluation framework and encourages the submission of studies at progressive stages, with a focus on device-based surgical and invasive treatments.
Editorial board
For information about BMJÂ Surgery, Interventions, & Health Technologies Editors-in-Chief Art Sedrakyan and Peter McCulloch and their editorial team, please refer to the Editorial Board page.
Ownership
BMJÂ Surgery, Interventions, & Health Technologies is wholly owned by the BMJ Publishing Group.
Journal information
Journal Statistics (2020)
Acceptance Rate: 67%
Speed
Time to first decision: 40 days (mean)
Time from acceptance to publication: 22 days (mean)
Reach
2020 total content views: 11,768
The impact that academic research has cannot be defined by one single metric. In 2013, BMJ signed the San Francisco Declaration on Research Assessment (DORA). We did this to show our support for using multiple measures and metrics to portray journals’ impact; moving away from the Impact Factor as a single measure.
Contact information
For all contact information, please refer to the contact us page.
Advertising
Online advertising – USA and Canada only
Jim Cunningham
jcunningham@cunnasso.com
Tel: +1 201.767.4170
Fax: +1 201.767.8065
Online advertising – All countries except USA and Canada
Mark Clifford
Email: mclifford@bmj.com
Information about advertising
Rights and permissions
Affiliations
BMJ Surgery, Interventions, & Health Technologies is an official journal of the International Society for Neurosurgical Technology and instrument invention (ISNTii). The society’s mission is to support the development, evaluation and dissemination of new technologies and instruments for the treatment of patients with disorders of the brain, spine and peripheral nerves.
BMJ is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.
The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting transparent, accurate reporting of research studies. BMJ is a sponsor of its activities.
BMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results reported.